Latest Carboplatin Stories
Clinical Study (003-011) to Assess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination with Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD)
- ABRAXANE plus gemcitabine to be PBS listed for Australian patients with metastatic pancreatic cancer from 1 November MELBOURNE, Australia, Oct.
Lawrence Livermore biomedical researcher Mike Malfatti is working with two researchers at the University of California, Davis, Comprehensive Cancer Center to leverage dramatic advances in biological
CALGARY, July 8, 2014 /PRNewswire/ - Oncolytics Biotech Inc.
Italian researchers say a treatment made from a human protein can help improve the effectiveness of chemotherapy for patients fighting malignant pleural mesothelioma. Raleigh,
Study Indicates Carboplatin Can Deliver Superior Performance When Compared to Other Chemotherapy Drugs Los Angeles, CA (PRWEB) June 19, 2014 A study
A new study suggests that platinum-based carboplatin reduces hospital stays and produces better outcomes for peritoneal mesothelioma patients than another popular drug. Raleigh,
PITTSBURGH, June 9, 2014 /PRNewswire/ -- Mylan Inc.
-- Difficult-to-treat squamous NSCLC patients saw clinical benefit with necitumumab plus chemotherapy regimen -- INDIANAPOLIS, May 14, 2014 /PRNewswire/ -- Lung cancer patients with
CALGARY, April 8, 2014 /PRNewswire/ - Oncolytics Biotech Inc.
- Large; stout; burly.